• Tags: IOLs
SpyGlass Pharma unveils positive 12-month data on BIM-IOL System
Research

SpyGlass Pharma unveils positive 12-month data on BIM-IOL System

Interim findings offer a closer look at the safety and efficacy of the bimatoprost drug pad-intraocular lens system for OAG and OHT.
FDA approves Rayner's RayOne Galaxy spiral IOL
Products

FDA approves Rayner's RayOne Galaxy spiral IOL

Touted as the world’s first-ever spiralized IOL, the AI-developed platform is now commercially available across the United States.
Real-world analysis ties enVista Aspire IOL to functional intermediate vision
Research

Real-world analysis ties enVista Aspire IOL to functional intermediate vision

Outcomes largely mirrored previous clinical findings, with most eyes achieving strong distance vision alongside functional intermediate acuity.
VirtuaLens launches expansion to VR IOL patient education platform
Products

VirtuaLens launches expansion to VR IOL patient education platform

Latest update to the customizable simulator allows patients to virtually mix and match different lens types to each eye prior to surgery.
Bausch + Lomb debuts IOL Compass framework for premium lens decisions
Events

Bausch + Lomb debuts IOL Compass framework for premium lens decisions

One-day-only, faculty-led surgeon education program routes candidacy, lens match, and post-op care into one system.
Omega Ophthalmics raises $7M to advance injectable IOL platform
Business

Omega Ophthalmics raises $7M to advance injectable IOL platform

Financing to support clinical development and future studies of a novel implant for cataract surgery; FDA-pre submission meeting is now scheduled.
Bausch + Lomb launches EyeGility Inserter preloaded IOL delivery system
Products

Bausch + Lomb launches EyeGility Inserter preloaded IOL delivery system

With an ergonomic design, the single-use, manual surgical instrument is specifically intended for preloaded enVista Aspire and Envy IOLs.
Alcon and RxSight partner to develop light-adjustable PCIOLs
Pipeline

Alcon and RxSight partner to develop light-adjustable PCIOLs

Non-exclusive deal will combine Alcon’s presbyopia-correcting IOL optical designs with RxSight’s customizable postop light-adjustable technology.
Johnson & Johnson expands US rollout of TECNIS PureSee IOL
Products

Johnson & Johnson expands US rollout of TECNIS PureSee IOL

The FDA-cleared, extended-depth-of-focus lens is the first of its kind with no warning on loss of contrast sensitivity.
SpyGlass Pharma: New add-on CPT code supports BIM-IOL System
Products

SpyGlass Pharma: New add-on CPT code supports BIM-IOL System

AMA approves application in conjunction with Category I cataract surgery codes; applies to investigational bimatoprost delivery system for IOP reduction in OAG and OHT.
Are blue-light blocking IOLs actually effective?
Research

Are blue-light blocking IOLs actually effective?

Yellow-tinted lenses were associated with a decline in macular pigment density over 3 years, the opposite of the intended effect.
ASCRS 2026 highlights key trends in surgical ecosystem
Events

ASCRS 2026 highlights key trends in surgical ecosystem

Annual meeting of cataract and refractive surgeons kicks off in the nation’s capital with focus on developments in surgical devices and IOLs.
Alcon launches Clareon TruPlus monofocal and toric IOL
Products

Alcon launches Clareon TruPlus monofocal and toric IOL

Latest next-gen IOL features the new Opti-Blance Technology design to increase DOF without sacrificing distance vision quality
VirtuaLens launches monovision simulation for VR IOL simulator
Products

VirtuaLens launches monovision simulation for VR IOL simulator

Immersive virtual reality IOL patient education system allows patients to “try on” lens options in a virtual setting ahead of cataract surgery.
High myopes face increased PCO risk with hydrophilic IOLs
Research

High myopes face increased PCO risk with hydrophilic IOLs

Study finds hydrophobic IOLs reduced the risk of PCO in highly myopic eyes by 41%.
FDA approves J&J's TECNIS PureSee IOL for cataract patients
Products

FDA approves J&J's TECNIS PureSee IOL for cataract patients

Approval is the first extended-depth-of-focus lens with no warning on loss of contrast sensitivity; availability to follow later this year.
FDA approves expanded age indication for STAAR's EVO/EVO+ Visian ICLs
Products

FDA approves expanded age indication for STAAR's EVO/EVO+ Visian ICLs

U.S. age indication now includes patients aged 21 to 60 years old, making nearly 8 million refractive patients eligible for implantable collamer lens implantation.
BVI reports first US implantations of FINEVISION HP Trifocal IOL
Products

BVI reports first US implantations of FINEVISION HP Trifocal IOL

Surgeon-led rollout includes five successful procedures across the country of the FDA-approved, presbyopia-correcting lens.
Study: enVista Aspire IOL delivers expanded intermediate vision without sacrificing distance
Research

Study: enVista Aspire IOL delivers expanded intermediate vision without sacrificing distance

Prospective study evaluates the enhanced monofocal IOL among patients undergoing standard phaco.
FDA approves BVI Medical's FINEVISION HP trifocal IOL
Products

FDA approves BVI Medical's FINEVISION HP trifocal IOL

Third-generation premium lens features a unique diffractive design while utilizing the proprietary CoPODize technology for minimized visual disturbances.